In a new study, researchers found colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn’t lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients. What’s more, it’s associated with a high risk of side effects, particularly diarrhea. Early =studies suggested that colchicine might be a useful addition to […]

The post Common gout drug cannot reduce severe COVID-19 or death appeared first on Knowridge Science Report.

…read more

Source:: Knowridge Science Report


(Visited 5 times, 1 visits today)

NASA Chooses Spacex To Launch A Self Propelled Space Station To The Moon

Leave a Reply

Your email address will not be published. Required fields are marked *